3.41 USD
-0.010.00%
盘后 3.49 +2.35%
2026-08-03
市值
$116.02M
市盈率
—
EPS
-0.30
股息率
—
52 周区间
2.32 – 5.46
成交量
194.71K
Beta
0.60
目标价
10.00
52W 低 2.3252W 高 5.46
价格走势
公司简介
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs comprising the development of liraltagene autoleucel, a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company also engaged in the development of a vaccine against breast cancer; and the development of a vaccine discovery program to develop additional cancer vaccines to addr...